SCHEMBL7180835

SCHEMBL7180835

Cc1cccc(C)c1C(=O)Pc1ccc(Oc2ccccc2)cc1.[LiH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2D6 P10635 1/20 0.43
LTA4H P09960 2/20 0.42
NR1H2 P55055 1/20 0.42
BAX Q07812 1/20 0.42
PTGS1 P23219 1/20 0.41
FFAR1 O14842 1/20 0.41
SRD5A2 P31213 3/20 0.40
PARP10 Q53GL7 1/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AKR1C3 P42330 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185568 0.90 FABP3 (0.40) MEN1KMT2ACYP2D6LTA4HNR1H2
SCHEMBL7177267 0.88 SRD5A2 (0.41) MEN1KMT2ACYP2D6LTA4HNR1H2
SCHEMBL7183622 0.85 L3MBTL1 (0.40) MEN1KMT2APTGS1FFAR1HPGD
SCHEMBL7183728 0.85 SRD5A2 (0.39) MEN1KMT2ACYP2D6LTA4HNR1H2
SCHEMBL7189515 0.84 ATM (0.42) MEN1KMT2AHPGDSMN1; SMN2NPC1
SCHEMBL27437106 0.84 L3MBTL1 (0.41) MEN1KMT2APTGS1FFAR1HPGD
SCHEMBL7183570 0.83 DAGLA (0.43) MEN1KMT2ALTA4HNR1H2BAX
SCHEMBL7179657 0.83 SRD5A2 (0.40) MEN1KMT2ACYP2D6LTA4HNR1H2
SCHEMBL7182351 0.83 KMT2A (0.46) MEN1KMT2ACYP2D6PTGS1FFAR1
SCHEMBL7183770 0.83 FABP3 (0.40) PTGS1FFAR1SMN1; SMN2LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1200943-C Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2005-05-11 CN disclosed
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
CN-1308081-A Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 MEN1 2312/4885KMT2A 1586/4885CYP2D6 1673/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 MEN1 2263/4885KMT2A 956/4885CYP2D6 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.